Gender, age and geographical representation over the past 50 years of schizophrenia research.

Age Diversity Gender Global diversity High-income countries Low-and-middle-income countries Schizophrenia

Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
01 2022
Historique:
received: 06 10 2021
accepted: 10 11 2021
pubmed: 4 12 2021
medline: 5 4 2022
entrez: 3 12 2021
Statut: ppublish

Résumé

Previous studies have suggested that subjects participating in schizophrenia research are not representative of the demographics of the global population of people with schizophrenia, particularly in terms of gender and geographical location. We here explored if this has evolved throughout the decades, examining changes in geographical location, gender and age of participants in studies of schizophrenia published in the last 50 years. We examined this using a meta-analytical approach on an existing database including over 3,000 studies collated for another project. We found that the proportion of studies and participants from low-and-middle income countries has significantly increased over time, with considerable input from studies from China. However, it is still low when compared to the global population they represent. Women have been historically under-represented in studies, and still are in high-income countries. However, a significantly higher proportion of female participants have been included in studies over time. The age of participants included has not changed significantly over time. Overall, there have been improvements in the geographical and gender representation of people with schizophrenia. However, there is still a long way to go so research can be representative of the global population of people with schizophrenia, particularly in geographical terms.

Identifiants

pubmed: 34861423
pii: S0165-1781(21)00574-6
doi: 10.1016/j.psychres.2021.114279
pmc: PMC8728886
mid: NIHMS1760528
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114279

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH110270
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH117434
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Nat Methods. 2021 Jun;18(6):577
pubmed: 34099932
World Psychiatry. 2008 Oct;7(3):148-56
pubmed: 18836582
Br J Psychiatry. 2001 May;178:406-9
pubmed: 11331553
Schizophr Bull. 2021 Jul 8;47(4):889-895
pubmed: 33948664
Arch Gen Psychiatry. 2003 Jun;60(6):565-71
pubmed: 12796219
Schizophr Res. 2010 Jun;119(1-3):240-5
pubmed: 20399612
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jan;4(1):8-15
pubmed: 30396768
Eur Neuropsychopharmacol. 2020 Aug;37:102
pubmed: 32684492
Int J Soc Psychiatry. 2010 Sep;56(5):497-506
pubmed: 19651690
Br J Psychiatry Suppl. 1998;172(33):53-9
pubmed: 9764127
Br J Psychiatry. 2015 Oct;207(4):288-92
pubmed: 26429682
Schizophr Res. 2018 Sep;199:458-460
pubmed: 29643010

Auteurs

Luz María Alliende (LM)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile; Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, United States.

Leticia S Czepielewski (LS)

Laboratory of Molecular Psychiatry, Centro de Pesquisa Clínica, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Programa de Pós-Graduação em Psicologia, Instituto de Psicología.Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.

David Aceituno (D)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile; Psychiatry and Mental Health Service, Complejo Asistencial Dr. Sótero del Río, Puente Alto, Chile.

Carmen Paz Castañeda (CP)

Early Intervention Program, Instituto Psiquiátrico José Horwitz Barak, Chile.

Camila Diaz (C)

Pharmacovigilance Program, Instituto Psiquiátrico José Horwitz Barak, Chile.

Barbara Iruretagoyena (B)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile; Department of Neurology and Psychiatry. Faculty of Medicine, Clínica Alemana Universidad del Desarrollo. Santiago, Chile.

Carlos Mena (C)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile; Institute of Cognitive Neuroscience, University College London, London, United Kingdom.

Cristian Mena (C)

Early Intervention Program, Instituto Psiquiátrico José Horwitz Barak, Chile; School of Medicine, Universidad Finis Terrae, Santiago, Chile.

Juan Pablo Ramirez-Mahaluf (JP)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile.

Ángeles Tepper (Á)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile.

Javiera Vasquez (J)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile.

Lais Fonseca (L)

Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of Sao Paulo, Brazil; Schizophrenia Program (PROESQ), Department of Psychiatry, Federal University of Sao Paulo, Brazil.

Viviane Machado (V)

Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of Sao Paulo, Brazil; Schizophrenia Program (PROESQ), Department of Psychiatry, Federal University of Sao Paulo, Brazil.

Camilo E Hernández (CE)

Department of Psychiatry, Faculty of Medicine, University of Antioquia, Colombia.

Cristian Vargas-Upegui (C)

Department of Psychiatry, Faculty of Medicine, University of Antioquia, Colombia.

Gladys Gomez-Cruz (G)

Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico.

Luis F Kobayashi-Romero (LF)

Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico.

Tomas Moncada-Habib (T)

Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico.

Sara Evans-Lacko (S)

Care Policy and Evaluation Centre, London School of Economics and Political Science, United Kingdom.

Rodrigo Bressan (R)

Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of Sao Paulo, Brazil.

Clarissa S Gama (CS)

Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Departamento de Psiquiatria e Medicina Legal, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.

Carlos Lopez-Jaramillo (C)

Department of Psychiatry, Faculty of Medicine, University of Antioquia, Colombia.

Camilo de la Fuente-Sandoval (C)

Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico.

Alfonso Gonzalez-Valderrama (A)

Early Intervention Program, Instituto Psiquiátrico José Horwitz Barak, Chile; School of Medicine, Universidad Finis Terrae, Santiago, Chile.

Juan Undurraga (J)

Early Intervention Program, Instituto Psiquiátrico José Horwitz Barak, Chile; Department of Neurology and Psychiatry. Faculty of Medicine, Clínica Alemana Universidad del Desarrollo. Santiago, Chile.

Ary Gadelha (A)

Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of Sao Paulo, Brazil; Schizophrenia Program (PROESQ), Department of Psychiatry, Federal University of Sao Paulo, Brazil.

Nicolas A Crossley (NA)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. Electronic address: ncrossley@uc.cl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH